Key protein molecule linked to diverse human chronic inflammatory diseases

September 16, 2008

Blacksburg, Va. -- Liwu Li, associate professor of biological sciences at Virginia Tech, has revealed a common connection between the cellular innate immunity network and human chronic inflammatory diseases, including atherosclerosis, Type 2 Diabetes, and neurodegenerative diseases. The finding presents a viable cellular and molecular target for the diagnosis and treatment of serious human inflammatory diseases, according to Li.

"Researchers and physicians have long recognized that there is an association between these conditions. For example, obesity increases the risk of heart attack or stroke, Type 2 Diabetes or insulin resistance, and Alzheimer's Disease," said Li, who is the founding director of the Inflammation Center at Virginia Tech.

"Inflammation is the common mechanism," he said. "Inflammation is a double-edged sword. Proper inflammation is necessary to fend off infection and abnormal cell growth. On the other hand, excessive inflammation contributes to diverse chronic diseases, including atherosclerosis, diabetes, and lupus." However, the complex cellular and molecular networks controlling inflammation are still poorly understood, he said. "The lack of understanding impedes our progress in treating serious chronic inflammatory diseases."

In a series of studies published throughout the last decade*, Li's group has defined several critical signaling networks essential for the modulation of inflammation. In particular, a key cellular protein kinase named interlukin-1 receptor associated kinase 1 (IRAK-1) was shown to be critical for processing diverse inflammatory signals, including microbial products, cytokines, and insulin. Li's group discovered that excessive IRAK-1 activation is linked with the risk of atherosclerosis and diabetes. Using transgenic mice without the IRAK-1 gene, Li's group demonstrated that IRAK-1 deficient mice are protected from developing atherosclerosis and insulin resistance.

At the molecular level, Li's laboratory discovered that IRAK-1 prefers to phosphorylate transcription factors harboring the Serine-Proline motif including STAT-3 and NFAT. Subsequently, STAT-3 and NFAT are involved in modulating the expression of distinct inflammatory mediators responsible for the excessive activation of specialized macrophages and T cells. These cells eventually contribute to diverse inflammatory symptoms including cardiovascular diseases, diabetes, Alzheimer's diseases, and lupus. "Chemical compounds targeting this molecule will have enormous therapeutic potential," Li said.

"There is still a long way to go for finding the actual cure for these diseases," he said. "That is why we are combining expertise from various disciplines, including experimental biology and computational simulation. The Inflammation Center integrates faculties with expertise in experimental molecular biology, cutting edge imaging of inflamed cells and tissues, computational simulation of cellular signaling networks, human and animal studies, and nano-technologies designing novel intervention."

Virginia Tech Intellectual Properties Inc. (VTIP) filed a patent application for Li's discovery and its use as a diagnostic tool and treatment strategy. "This technology will still take some time before there is a product," said Li.

Virginia Tech

---

---

	Experimental models of chronic inflammatory diseases by L. E.; Schlumberger, H.D. Glynn (Author)
	The Inflammation Syndrome: Your Nutrition Plan for Great Health, Weight Loss, and Pain-Free Living by Jack Challem (Author) Completely revised and updated-Jack Challem's powerful plan to safely prevent and overcome inflammatory disordersInflammation is what happens when our body's own defenses turn on us-and it is a huge and growing problem. Written by the author of the groundbreaking Syndrome X, this essential updated edition of The Inflammation Syndrome draws on cutting-edge research conducted around the world to provide a revolutionary approach to healing inflammation-related problems through an easy-to-follow nutrition and supplement program.Includes new recommendations for individualized diet and supplement plansPresents fourteen steps for restoring dietary balance, plus recipes and menu plans Reveals the powerful role inflammation plays in a wide variety of common health conditions–from simple aches...
	Chronic Inflammatory Bowel Disease (Falk Symposium) by E.-F. Stange (Editor) Chronic inflammatory bowel disease still represents a major gastroenterological challenge, in view of the unclear aetiology and unsatisfactory therapy. This book, the proceedings of a Falk Symposium held in Lübeck, Germany on 4--5 March 1994, will act as a vehicle for our current knowledge, and promote the dialogue between clinicians and those involved with the associated sciences. The book begins with international experts discussing the more recent theories concerning the aetiology and pathogenesis. Later on, the discussion turns to questions of diagnosis, and the conservative and surgical treatment of Crohn's disease and ulcerative colitis are dealt with in detail. This volume in the Falk Symposium both represents a forum of experts for discussion of the most recent...
	The Inflammation Syndrome: The Complete Nutritional Program to Prevent and Reverse Heart Disease, Arthritis, Diabetes, Allergies, and Asthma by Jack Challem (Author) Early Acclaim for The Inflammation Syndrome "Challem's new book hits a home run-with the latest research on what to eat and take to defeat our real number-one cause of health problems-inflammation. It's a message of the utmost importance." -Jean Carper, New York Times bestselling author of Stop Aging Now! and Your Miracle Brain, and columnist, USA Weekend magazine "Treating and preventing inflammation has become a major priority and a breakthrough in today's medicine. Many of our most debilitating diseases can be traced to an inflammatory cause. The program Jack Challem outlines in The Inflammation Syndrome is a great first step in ridding your body of this deadly problem." -Fred Pescatore, M.D., author of Thin For Good, The Allergy and Asthma Cure, and Feed Your Kids...
	The link between dialysate and chronic inflammatory disease in hemodialysis. (Clinical Consult).: An article from: Nephrology Nursing Journal by Rebecca L. Amato (Author) This digital document is an article from Nephrology Nursing Journal, published by Jannetti Publications, Inc. on October 1, 2002. The length of the article is 2282 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: The link between dialysate and chronic inflammatory disease in hemodialysis. (Clinical Consult). Author: Rebecca L. Amato Publication: Nephrology Nursing Journal (Refereed) Date: October 1, 2002 Publisher: Jannetti Publications, Inc. Volume: 29 Issue: 5 Page: 490(3) Distributed by Thomson...
	Living Well with Autoimmune Disease: What Your Doctor Doesn't Tell You...That You Need to Know by Mary J. Shomon (Author) A complete guide to understanding the mysterious and often difficult-to-pinpoint disorders of the immune system--and finding the keys to diagnosis, treatment, and recovery. An estimated fifty million people suffer from symptoms including fatigue, joint pains, depression, or heart palpitations — signs that the immune system has turned on itself, causing conditions such as thyroid disease, hepatitis, or multiple sclerosis. And while doctors may prescribe treatments to relieve these surface ailments, when asked about the life-long health implications of an autoimmune condition, they often just shrug their shoulders. Yet much like cancer, having one autoimmune disease puts you at high risk for developing another, and understanding the underlying immune process can reverse a patients...
	Targets of Treatment in Chronic Inflammatory Bowel Diseases (Falk Symposium) by H. Herfarth (Editor), B.G. Feagan (Editor), U.R. Fölsch (Editor), J. Schölmerich (Editor), M.H. Vatn (Editor), M. Zeitz (Editor) The first gene responsible for Crohn's disease has now been identified and the pathophysiological understanding of inflammatory bowel disease as well as its practical treatment have made much progress in recent years. Thus it is obviously important to consider the targets and the aims of treatment in context. The Falk Symposium No. 131 (Part II of the Gastroenterology Week Freiburg 2002), held in October 2002 in Freiburg, Germany, in its first part was dedicated to newly defined and partly alternative therapeutic targets. In addition, an attempt was made to learn from experts from other fields such as pneumology or dermatology. The second part was dedicated to the aims of treatment in daily practice. Aside from general treatment, aims such as amelioration of symptoms, pre-conditions of...
	Chronic inflammatory bowel disease by James L Achord (Author)
	The Craniovertebral Region in Chronic Inflammatory Rheumatic Diseases by Yves Dirheimer (Author), A. Wackenheim (Foreword)
	What Your Doctor May Not Tell You about Heart Disease by Mark Houston (Author) Coronary heart disease has long been the number one killer in this country, and for decades, we have been told about five basic risk factors: elevated cholesterol, high blood pressure, diabetes, obesity, and smoking. But the truth is that heart disease is much more complex-- with close to 400 risk factors! In this innovative guide, Dr. Mark Houston helps readers discover the causes of heart disease, how to prevent and treat its debilitating effects via nutrition, nutritional supplements, exercise, weight management, and lays to rest to various myths (cholesterol is not the primary cause) based on scientific studies and medical publications. Readers will also learn how to indentify the risk factors most likely to endager them and construct an arsenal of non-pharmacological...